Literature DB >> 29062774

Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography.

Rodolfo Mastropasqua1, Lisa Toto2, Alessandra Mastropasqua2, Raffaella Aloia2, Chiara De Nicola2, Peter A Mattei2, Guido Di Marzio2, Marta Di Nicola3, Luca Di Antonio2.   

Abstract

AIM: To investigate foveal avascular zone (FAZ) and parafoveal vessel densities (PRVD) by means of optical coherence tomography angiography (OCTA) in diabetic patients with or without diabetic retinopathy (DR) and to assess the reproducibility of FAZ and PRVD measurements.
METHODS: Sixty diabetic patients (60 eyes) with different stage of DR (graded according to the International Clinical Severity Scale for DR) and 20 healthy subjects underwent FAZ area and PRVD measurements using OCTA by two experienced examiners. FAZ area in all patients was also assessed using fluorescein angiography (FA).
RESULTS: In subject with proliferative DR and with moderate-severe non proliferative DR, FAZ area was significantly increased compared to healthy controls (P=0.025 and P=0.050 respectively measured with OCTA and P=0.025 and P=0.048 respectively measured with FA). OCTA showed significantly less inter-observer variability compared to FA. Concordance correlation coefficient (CCC) for FAZ area measurements was 0.829 (95%CI: 0.736-0.891) P<0.001 with FA and 1.000 (95%CI: 0.999-1.000) P<0.001 with OCTA. CCC was 0.834 (95%CI: 0.746-0.893) P<0.001 and 0.890 (95%CI: 0.828-0.930) P<0.001 for parafoveal superficial and deep vessel density measurements, respectively.
CONCLUSION: OCTA shows progressive increase of FAZ area and reduction of PRVD in both superficial and deep plexus at increasing DR severity. FAZ area and PRVD measurements using OCTA are highly reproducible.

Entities:  

Keywords:  diabetic retinopathy; fluorescein angiography; optical coherence tomography angiography

Year:  2017        PMID: 29062774      PMCID: PMC5638976          DOI: 10.18240/ijo.2017.10.11

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  28 in total

1.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

2.  Absence of foveal avascular zone demonstrated by laser scanning fluorescein angiography.

Authors:  B Sander; M Larsen; C Engler; H Lund-Andersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1994-10

3.  Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment.

Authors:  J Conrath; R Giorgi; D Raccah; B Ridings
Journal:  Eye (Lond)       Date:  2005-03       Impact factor: 3.775

Review 4.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

Review 5.  Fluorescein angiography complication survey.

Authors:  L A Yannuzzi; K T Rohrer; L J Tindel; R S Sobel; M A Costanza; W Shields; E Zang
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

6.  Foveal avascular zone in diabetes mellitus.

Authors:  A M Mansour; A Schachat; G Bodiford; R Haymond
Journal:  Retina       Date:  1993       Impact factor: 4.256

7.  Retinal vessel response to flicker light in children and adolescents with type 1 diabetes mellitus and overweight or obesity.

Authors:  Ralf Schiel; Walthard Vilser; Felix Kovar; Guido Kramer; Anke Braun; Günter Stein
Journal:  Diabetes Res Clin Pract       Date:  2008-12-18       Impact factor: 5.602

8.  The spectrum of superficial and deep capillary ischemia in retinal artery occlusion.

Authors:  Suqin Yu; Claudine E Pang; Yuanyuan Gong; K Bailey Freund; Lawrence A Yannuzzi; Ehsan Rahimy; Brandon J Lujan; Homayoun Tabandeh; Michael J Cooney; David Sarraf
Journal:  Am J Ophthalmol       Date:  2014-09-22       Impact factor: 5.258

Review 9.  Current concepts in diabetic retinopathy.

Authors:  Su Jeong Song; Tien Yin Wong
Journal:  Diabetes Metab J       Date:  2014-12       Impact factor: 5.376

10.  Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy.

Authors:  Florentina J Freiberg; Maximilian Pfau; Juliana Wons; Magdalena A Wirth; Matthias D Becker; Stephan Michels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-04       Impact factor: 3.117

View more
  34 in total

1.  Within-subject assessment of foveal avascular zone enlargement in different stages of diabetic retinopathy using en face OCT reflectance and OCT angiography.

Authors:  Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui
Journal:  Biomed Opt Express       Date:  2018-11-05       Impact factor: 3.732

2.  Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.

Authors:  Osama A Sorour; Almyr S Sabrosa; A Yasin Alibhai; Malvika Arya; Akihiro Ishibazawa; Andre J Witkin; Caroline R Baumal; Jay S Duker; Nadia K Waheed
Journal:  Int Ophthalmol       Date:  2019-05-22       Impact factor: 2.031

3.  Evaluation of retinal vessel density and foveal avascular zone measurements in patients with obstructive sleep apnea syndrome.

Authors:  Mustafa Çolak; Dilay Özek; Kürşat Murat Özcan; Fakih Cihat Eravcı; Süleyman Emre Karakurt; Mehmet Fatih Karakuş; Özlem Evren Kemer
Journal:  Int Ophthalmol       Date:  2021-01-08       Impact factor: 2.031

4.  Foveal avascular zone analysis by optical coherence tomography angiography in patients with type 1 and 2 diabetes and without clinical signs of diabetic retinopathy.

Authors:  Giovanni William Oliverio; Ida Ceravolo; Ahsan Bhatti; Costantino John Trombetta
Journal:  Int Ophthalmol       Date:  2020-11-06       Impact factor: 2.031

5.  Earliest Evidence of Preclinical Diabetic Retinopathy Revealed Using Optical Coherence Tomography Angiography Perfused Capillary Density.

Authors:  Richard B Rosen; Jorge S Andrade Romo; Brian D Krawitz; Shelley Mo; Amani A Fawzi; Rachel E Linderman; Joseph Carroll; Alexander Pinhas; Toco Y P Chui
Journal:  Am J Ophthalmol       Date:  2019-01-26       Impact factor: 5.258

6.  Evaluation of the effect of the severity of diabetic retinopathy on microvascular abnormalities and vascular density using optical coherence tomography angiography.

Authors:  Héla Kaoual; Imène Zhioua Braham; Mejdi Boukari; Raja Zhioua
Journal:  Acta Diabetol       Date:  2021-07-27       Impact factor: 4.280

7.  Statistical Model of Optical Coherence Tomography Angiography Parameters That Correlate With Severity of Diabetic Retinopathy.

Authors:  Mohammed Ashraf; Peter L Nesper; Lee M Jampol; Fei Yu; Amani A Fawzi
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

8.  Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy.

Authors:  David Cordeiro Sousa; Inês Leal; Susana Moreira; Sónia do Vale; Ana R Silva-Herdade; Patrícia Dionísio; Miguel A R B Castanho; Luís Abegão Pinto; Carlos Marques-Neves
Journal:  Eye (Lond)       Date:  2019-07-04       Impact factor: 3.775

Review 9.  Quantitative optical coherence tomography angiography: A review.

Authors:  Xincheng Yao; Minhaj N Alam; David Le; Devrim Toslak
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-20

10.  Analyzing Relative Flow Speeds in Diabetic Retinopathy Using Variable Interscan Time Analysis OCT Angiography.

Authors:  Malvika Arya; Marco Bonini Filho; Carl B Rebhun; Eric M Moult; Byungkung Lee; Yasin Alibhai; Andre J Witkin; Caroline R Baumal; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Ophthalmol Retina       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.